• Catassi, C., Bearzi, I. & Holmes, G.K. (2005) Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology, 128, S7986.
  • Daum, S., Ullrich, R., Heise, W., Dederke, B., Foss, H.D., Stein, H., Thiel, E., Zeitz, M. & Riecken, E.O. (2003) Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. Journal of Clinical Oncology, 21, 27402746.
  • Gale, J., Simmonds, P.D., Mead, G.M., Sweetenham, J.W. & Wright, D.H. (2000) Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. Journal of Clinical Oncology, 18, 795803.
  • Honemann, D., Prince, H.M., Hicks, R.J. & Seymour, J.F. (2005) Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options. Annals of Hematology, 84, 118121.
  • Jaffe, E.S., Krenacs, L. & Raffeld, M. (2003) Classification of cytotoxic T-cell and natural killer cell lymphomas. Seminars in Hematology, 40, 175184.
  • Jantunen, E., Juvonen, E., Wiklund, T., Putkonen, M. & Nousiainen, T. (2003) High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma. Leukemia & Lymphoma, 44, 21632164.
  • McQuaker, I.G., Haynes, A.P., Stainer, C., Anderson, S. & Russell, N.H. (1997) Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. British Journal of Haematology, 98, 228233.
  • Obermann, E.C., Diss, T.C., Hamoudi, R.A., Munson, P., Wilkins, B.S., Camozzi, M.L., Isaacson, P.G., Du, M.Q. & Dogan, A. (2004) Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma. Journal of Pathology, 202, 252262.
  • Okuda, M., Nomura, J., Tateno, H., Kameoka, J. & Sasaki, T. (2002) CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation. Internal Medicine, 41, 734737.
  • Piekarz, R. & Bates, S. (2004) A review of depsipeptide and other histone deacetylase inhibitors in clinical trials. Current Pharmaceutical Design, 10, 22892298.
  • Quintanilla-Martinez, L., Lome-Maldonado, C., Ott, G., Gschwendtner, A., Gredler, E., Angeles-Angeles, A., Reyes, E. & Fend, F. (1998) Primary intestinal non-Hodgkin's lymphoma and Epstein-Barr virus: high frequency of EBV-infection in T-cell lymphomas of Mexican origin. Leukemia & Lymphoma, 30, 111121.
  • Verkarre, V., Romana, S.P., Cellier, C., Asnafi, V., Mention, J.J., Barbe, U., Nusbaum, S., Hermine, O., Macintyre, E., Brousse, N., Cerf-Bensussan, N. & Radford-Weiss, I. (2003) Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology, 125, 4046.